Halozyme Therapeutics, Inc. (HALO): Price and Financial Metrics

HALO POWR Grades

• HALO scores best on the Value dimension, with a Value rank ahead of 87.6% of US stocks.
• HALO's strongest trending metric is Growth; it's been moving up over the last 177 days.
• HALO ranks lowest in Momentum; there it ranks in the 3rd percentile.

HALO Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for HALO is 5.12 -- better than 91.03% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 14.92 for HALOZYME THERAPEUTICS INC; that's greater than it is for 95.69% of US stocks.
• As for revenue growth, note that HALO's revenue has grown 58.71% over the past 12 months; that beats the revenue growth of 90.86% of US companies in our set.
• Stocks that are quantitatively similar to HALO, based on their financial statements, market capitalization, and price volatility, are PRGS, CMTL, IPGP, VERI, and NTCT.
• HALO's SEC filings can be seen here. And to visit HALOZYME THERAPEUTICS INC's official web site, go to www.halozyme.com.

HALO Valuation Summary

• In comparison to the median Healthcare stock, HALO's price/sales ratio is 252.63% higher, now standing at 6.7.
• HALO's EV/EBIT ratio has moved up 138.5 over the prior 238 months.

Below are key valuation metrics over time for HALO.

HALO Growth Metrics

The 5 year price growth rate now stands at 79.34%.
• The 5 year net income to common stockholders growth rate now stands at 30.98%.
• The 2 year cash and equivalents growth rate now stands at 12.36%.

Over the past 52 months, HALO's revenue has gone up $378,922,000.

The table below shows HALO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	660.116	240.11	202.129
2022-09-30	580.623	240.173	211.197
2022-06-30	487.477	292.277	366.15
2022-03-31	471.567	288.941	434.923
2021-12-31	443.31	299.44	402.71
2021-09-30	463.01	267.844	409.104

HALO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• HALO has a Quality Grade of C, ranking ahead of 73.97% of graded US stocks.
• HALO's asset turnover comes in at 0.493 -- ranking 84th of 682 Pharmaceutical Products stocks.
• ARAV, XOMA, and MGNX are the stocks whose asset turnover ratios are most correlated with HALO.

The table below shows HALO's key quality metrics over time.